Managing adolescent acne
- PMID: 11404206
Managing adolescent acne
Abstract
Acne vulgaris, more commonly termed acne, is the most common skin disease treated by physicians. It affects an estimated 17 million people in the United States, including 85% or more of adolescents and young adults. Acne is a chronic condition that may last for years and cause emotional distress and permanent scarring. Although there is no cure, medications can control the disease and limit or prevent scar formation.
Similar articles
-
Acne in adolescents. Need for treatment is more than skin deep.Adv Nurse Pract. 1999 Apr;7(4):53-6. Adv Nurse Pract. 1999. PMID: 10382388 Review. No abstract available.
-
Acne and acne scarring - the case for active and early intervention.Aust Fam Physician. 2006 Jul;35(7):503-4. Aust Fam Physician. 2006. PMID: 16820822 Review.
-
Overview of the evaluation and management of acne vulgaris.Pediatr Nurs. 2003 Jul-Aug;29(4):287-93; quiz 294-5. Pediatr Nurs. 2003. PMID: 12956549 Review.
-
Changing the topography of acne with topical medications.Curr Opin Pediatr. 2011 Feb;23(1):121-5. doi: 10.1097/MOP.0b013e3283425457. Curr Opin Pediatr. 2011. PMID: 21191297 Review.
-
Anger and acne: implications for quality of life, patient satisfaction and clinical care.Br J Dermatol. 2004 Jul;151(1):183-9. doi: 10.1111/j.1365-2133.2004.06078.x. Br J Dermatol. 2004. PMID: 15270889
Cited by
-
Efficacy of Spironolactone in Adult Acne in Polycystic Ovary Syndrome Patients an Original Research.J Pharm Bioallied Sci. 2021 Nov;13(Suppl 2):S1659-S1663. doi: 10.4103/jpbs.jpbs_391_21. Epub 2021 Nov 10. J Pharm Bioallied Sci. 2021. PMID: 35018050 Free PMC article.
-
Spironolactone in the treatment of polycystic ovary syndrome: effects on clinical features, insulin sensitivity and lipid profile.J Endocrinol Invest. 2005 Jan;28(1):49-53. doi: 10.1007/BF03345529. J Endocrinol Invest. 2005. PMID: 15816371 Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Medical